GLP-1 heart rate, HRV & anxiety: what the labels actually say

A practical, non-prescriptive way to separate documented heart-rate findings from wearable patterns and unanswered anxiety questions.

Reviewed against current DailyMed prescribing information: July 2026
The short answer: official Wegovy and Zepbound prescribing information reports small average increases in resting heart rate in weight-reduction trials. Those averages do not tell you what caused one person's HRV or anxiety change. Use a timeline to preserve the facts, then bring persistent or concerning changes to a licensed clinician.

What the prescribing information documents

The strongest evidence on this page is narrow: the heart-rate language in the U.S. prescribing information. It supports a modest average effect at the study-group level, not a diagnosis for an individual wearable reading.

Medication Documented finding What it means here
Wegovy (semaglutide) Mean resting-heart-rate increases of 1 to 4 bpm were observed in Wegovy injection-treated adults compared with placebo in weight-reduction trials. [Current DailyMed “Increase in Heart Rate” text] The label supports the possibility of a higher resting heart rate. It does not predict the size or timing of one person's change.
Zepbound (tirzepatide) Across pooled Studies 1 and 2, Zepbound produced a mean heart-rate increase of 1 to 3 bpm, compared with no increase in placebo-treated patients. [Zepbound label] This is also an average trial finding, not a personal threshold or a day-by-day forecast.

What these sources do not establish

That uncertainty is why this page focuses on a clean history instead of a mechanism story. Record what changed, when it changed, and what else changed in the same window.

Build a timeline that another person can read

A useful log separates observations from interpretations. Keep the raw details first; leave the cause blank until the pattern has been reviewed.

Medication context

  • Medication name
  • Injection date and approximate time
  • Whether the prescribed regimen changed
  • Other medications or stimulants that changed

Wearable context

  • Resting heart rate and HRV value
  • Device and time of measurement
  • Your own recent baseline from that device
  • Whether the change repeated

Symptom context

  • What you felt, in plain language
  • When it began and ended
  • Whether it occurred while resting
  • What made it better or worse

Same-window context

  • Sleep duration or disruption
  • Caffeine or alcohol
  • Illness, travel, or unusual stress
  • Any substantial change in food or fluid intake

Write the note so it remains useful later

Observation: “Tuesday morning, resting heart rate was 78 on the same watch that showed a recent baseline near 67. I also felt uneasy while sitting.”

Context: “Injection was Sunday evening. Sleep was shorter Monday night. Caffeine was unchanged.”

Unknown: “I do not know whether the medication, sleep, or something else caused the change.”

Questions to bring to a clinician

Medication, dose, and schedule decisions belong with the prescriber and the current product label. If a symptom feels urgent, use urgent medical care rather than a tracking guide.

Keep injection timing accurate; keep HRV interpretation honest

Jabbit supports smart scheduling, quick logging, and smart site rotation across 14 injection zones. Keep the HRV reading in the wearable app that produced it, then compare the two timelines without implying Jabbit stores or interprets HRV.

View Jabbit in the App Store →

Jabbit is a tracking tool, not a medical device or a substitute for clinical care.

Frequently asked questions

Do GLP-1 medications raise resting heart rate?

The labels cited here report modest average increases in weight-reduction trials: 1 to 4 bpm for Wegovy injection versus placebo, and 1 to 3 bpm for Zepbound versus no placebo increase. Individual responses can differ from a group average.

Does a lower HRV reading prove my injection caused it?

No. Timing is worth documenting, but a sequence alone does not establish cause. These labels provide heart-rate findings, not a predictable post-injection HRV curve.

Can this page tell me whether anxiety came from the medication?

No. It can help you preserve the timeline and the surrounding context. It cannot diagnose the cause of anxiety or tell you how to change treatment.

Primary sources

  1. DailyMed: Wegovy (semaglutide) current U.S. prescribing information — see the current “Increase in Heart Rate” text.
  2. DailyMed: Zepbound (tirzepatide) current U.S. prescribing information — see “Heart Rate Increase” in Clinical Trials Experience.

DailyMed is a service of the U.S. National Library of Medicine. Product labeling can change; use the live source rather than a copied dose or warning summary.